Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Thromboembolism × Dalteparin × Clear all

Phase

Status

Completed 2 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thromboembolism 1 Stomach Neoplasms 1 Pancreatic Neoplasms 1 Lung Neoplasms 1 Gastrointestinal Stromal Tumors 1 Gallbladder Neoplasms 1 Esophageal Neoplasms 1 Duodenal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Biliary Tract Neoplasms 1

Interventions

palbociclib 1 Tinzaparin 1 Rivaroxaban 1 Heparin, Low-Molecular-Weight 1 Dalteparin 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00519805 2011-08-08

Dalteparin in Preventing Blood Clots in Patients With Lung Cancer

National Cancer Institute (NCI)

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡